Regulation - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

176 to 200 of 238 results

US and Indian biotech industry find common ground on key issues

13-09-2012

The third annual BIO India conference kicked off yesterday in Mumbai with significant agreement among…

Asia-PacificBiotechnologyNorth AmericaPatentsRegulationResearch

India, WHO and PSM India to collaborate to curb spurious and sub-standard medicines

10-09-2012

At an international workshop in New Delhi, it was announced that the Indian government, the World Health…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalProductionRegulation

Australia leading world in medicines Code, claims trade group

09-09-2012

Australia is a world leader in pharmaceutical industry conduct, and will continue to work towards further…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

Dainippon Sumitomo files for approval of Calsed in China

06-09-2012

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has submitted an imported drug registration…

Asia-PacificCalsedDainippon Sumitomo PharmaOncologyPharmaceuticalRegulation

Eisai gets South Korean approval for breast cancer drug Halaven

04-09-2012

The South Korean sales subsidiary of Japanese drug major Eisai (TYO: 4523) has received approval from…

Asia-PacificEisaiHalavenOncologyPharmaceuticalRegulation

Otsuka files Abilify, first antipsychotic for major depressive disorder in Japan

04-09-2012

Japanese drugmaker Otsuka Pharmaceutical (TYO: 4768) has filed an additional indication for Abilify (aripiprazole)…

AbilifyAsia-PacificNeurologicalOtsukaPharmaceuticalRegulation

Novo Nordisk insulin degludec passes first regulatory hurdle in Japan

03-09-2012

Danish insulin giant Novo Nordisk (NOV: N) revealed on Friday that its ultra-long-acting insulin degludec…

Asia-PacificDegludecDiabetesNovo NordiskPharmaceuticalRegulation

Medicines Australia sets up new taskforce on transparency for payments to doctors

14-08-2012

Medicines Australia has invited the Australian Medical Association, the Royal Australian College of Physicians,…

Asia-PacificFinancialMarkets & MarketingPharmaceuticalRegulationResearch

Shionogi partner Ildong gains South Korean approval for Pirespa

14-08-2012

Japanese drug major Shionogi (TYO: 4507) says that its South Korean partner Ildong Pharma has received…

Asia-PacificIldong PharmaPharmaceuticalPirespapirfenidoneRegulationRespiratory and PulmonaryShionogi

Japanese filings for Shionogi's metreleptin and Otsuka's tolvaptin

06-08-2012

Japanese drugmaker Shionogi (TYO: 4507) said last week that it has filed a New Drug Application with…

Asia-PacificmetreleptinNephrology and HepatologyOtsukaPharmaceuticalRare diseasesRegulationSamscaShionogitolvaptin

EMA increases interaction with Japanese regulators

30-07-2012

The European Medicines Agency has increased its level of interaction and cooperation with medicines regulatory…

Asia-PacificBiotechnologyEuropePharmaceuticalRare diseasesRegulation

Australia's health care regulations struggle to keep up with population aging

10-07-2012

The growing elderly population and its associated disease burden add to the economic challenges faced…

Asia-PacificHealthcareMarkets & MarketingPharmaceuticalPricingRegulation

Australian pharma companies to disclose payments to doctors under new Code of Conduct

06-07-2012

Australian pharma trade group Medicines Australia says that its new Code of Conduct will require member…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

New Zealand agrees to fund Iressa but amends Tarceva use

05-07-2012

New Zealand's pharmaceutical management agency PHARMAC has approved the proposal to fund AstraZeneca's…

Asia-PacificAstraZenecaIressaOncologyPharmaceuticalPricingRegulationRocheTarceva

Russia urged to open up its pharmaceuticals market to Indian imports

04-07-2012

Russia should open its booming $19 billion pharmaceuticals market and expedite the list of 500 drugs…

Asia-PacificEuropeGenericsMarkets & MarketingPoliticsRegulation

Teijin and Ipsen's Somatuline cleared in Japan

01-07-2012

Japanese drugmaker Teijin Pharma (TYO: 3402) revealed last Friday that it has received manufacturing…

Asia-PacificIpsenPharmaceuticalRare diseasesRegulationSomatulineTeijin

Australia's Greens want end to Big Pharma inducements

28-06-2012

Ahead of an announcement by pharma trade group Medicines Australia on a new Code of Conduct this week,…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Australian patients to benefit from new PBS listings; OTC reforms

26-06-2012

The listing of 11 prescription medicines on the Australian Pharmaceutical Benefits Scheme (PBS) has been…

Asia-PacificBiotechnologyHealthcarePharmaceuticalPricingRegulation

SkyePharma partner Kyorin completes Japanese Flutiform clinical program

26-06-2012

UK drug delivery specialist SkyePharma (LSE: SKP) saw its shares leap nearly 11% to £76.50 last…

Asia-PacificFlutiformKyorin PharmaceuticalsPharmaceuticalRegulationResearchRespiratory and PulmonarySkyepharma

Australian medicines could lead the way for manufacturing in the "Asian century"

17-06-2012

If supported by good public policy, medicines could play a significant role in ensuring Australia adapts…

Asia-PacificGenericsMarkets & MarketingPatentsRegulation

Osiris gets second approval for Prochymal, in New Zealand

15-06-2012

USA-based Osiris Therapeutics (Nasdaq: OSIR) has received a second approval to market its first-in-class…

Asia-PacificBiotechnologyImmunologicalsOsiris TherapeuticsProchymalRegulation

Australia's PIC reports to Ministers on treatment and reimbursement of similar biologics

14-06-2012

The Australian Pharmaceuticals Industry Council (PIC), with industry group members AusBiotech, Medicines…

Asia-PacificBiotechnologyGenericsPharmaceuticalPricingRegulation

176 to 200 of 238 results

Back to top